Dans le cadre du projet scientifique Capes-Cofecub Me1080/25 (Brésil-France), la Dr. Rose-Anne Lavergne et le Prof. Florent Morio se rendent au Brésil du 27 novembre au 6 décembre 2025.

Ils iront d'abord à Belo Horizonte - Minas Gerais puis à Botucatu Campus, São Paulo.

Ils délivreront 2 conférences lors du Brazilian Network Meeting: Aspergillus fumigatus Antifungal Resistance – Protecting Health in the Face of Agricultural Pressures (du 3 au 5/12/25 à UNESP Botucatu Campus, São Paulo, Brazil) sur les sujets "Clinical cases of Aspergillus fumigatus in France and adopting a One Health approach" (Dr. R.-A. Lavergne) et "The Candida parapsilosis case – antifungal resistance under One Health. Brazilian network meeting for antifungal resistance in Aspergillus fumigatus: protecting health in the face of agricultural pressures.

Dans le cadre du projet ANR FungiSol porté par Isabelle Ourliac-Garnier et du partenariat avec le Pôle Séquoia de la mairie de Nantes, Rose-Anne Lavergne, Marjorie Albassier, Thomas Ferran et Auriane Fraix animeront un atelier pour des enfants (et leurs parents ), le 22 octobre 2025 de 14h à 17h.

Toutes les informations sont ici : https://metropole.nantes.fr/que-faire-nantes/agenda/atelier-enfants-parents-les-mysteres-du-sol-8497404

We were delighted to take part in the REC’n’Play event in Recife, Brazil (https://recnplay.pe/), contributing to a rich roundtable discussion on innovation in healthcare, exploring new opportunities and perspectives for partnerships between Brazil and France.

Presentation available here: https://uncloud.univ-nantes.fr/index.php/s/eRFxQnbqxw3Ktjk
It was also a great pleasure to share our latest research results on Leishmania CK1 inhibitors (Prof. Pascal Marchand), but also Candida auris (Dr. Isabelle Ourliac-Garnier) during a seminar of the Postgraduate Program in Therapeutic Innovation (PPGIT) at Universidade Federal de Pernambuco, thanks to the kind invitation of Prof. Teresinha Silva and Prof. Moacyr Jesus Barreto de Melo Rêgo.
These 10 years have been marked by inspiring mobilities and fantastic outcomes:
📚 Numerous publications and conference presentations
🎓 7 cotutelle PhD students
🧑‍🔬 4 postdoctoral researchers
🌎 3 MedChem scientific events involving 6 brazilian institutions
A heartfelt thank you to all partners and collaborators who made this journey possible — and to the next decade of shared discoveries and innovation! 😀 🚀

Dans le cadre du projet scientifique Capes-Cofecub Me1009/23 (Brésil-France), la Dr. Isabelle Ourliac-Garnier et le Prof. Pascal Marchand se rendent au Brésil du 15 au 25 octobre 2025.

A l'invitation de la chargée de mission coopération scientifique à l’ambassade de France à Brasilia et du directeur du SECTI (Secretaria de Ciência, Tecnologia e Inovação do Estado de Pernambuc) à Recife, ils participeront au festival Rec'N'Play (https://recnplay.pe/, 15-18 octobre 2025), dédié à l'innovation par la mise en place d'un espace France et qui permet de présenter des projets/expositions/conférences. 

La mobilité s’effectuera en 2 temps :

D’abord à Recife-Pernambouc (15-19 octobre) avec le festival Rec'N'Play et aussi une présentation devant les doctorants, postdoctorants et chercheurs brésiliens de l’ED  « Innovation Thérapeutique » à L’université Fédéral de Pernambuco (UFPE)

IOG : Uncovering Candida auris (Candidozyma auris) in the environment: First isolation in costal lands of British Columbia

PM : Casein kinase 1 - A target for the treatment of infectious diseases?

Dr. Isabelle Ourliac-Garnier & Prof. Pascal Marchand iront ensuite à Maceió-Alagoas (UFAL) pour participer à un symposium « Program in Chemistry and Biotechnology (SIMPPGQB), comme conférenciers.

IOG : From Pathways to Practice. Sterol Biosynthesis in Fungi: Role and Applications in Medical Mycology

PM : Casein kinase 1 inhibition as a novel strategy for the design of anti-infective agents

Le 25 septembre 2025, le Dr. Marc-Antoine Bazin a prononcé à l'Université d'Assiout - Egypte une conférence intitulée : "Advancing medicinal chemistry through novel heterocyclic frameworks for anti-infective and antiproliferative strategies".

Ceci dans le cadre d'une mobilité scientifique du PHC Imhotep N°50393UJ, financée par Campus France (porteur du projet : Dr N. Primas, Aix-Marseille Université). 

We are pleased to welcome back Nakã Kadri from the Faculty of Science at the université de Sfax - University of Sfax (USS) - Tunisie (Prof. houcine Houcine_Fss Ammar), to the IICiMed Lab! She will be spending six months at Nantes Université working on an exciting project dedicated to developing new heterocyclic compounds as anti-infective agents.
We are also excited to welcome Letizia Frongia from the Università degli Studi di Cagliari, Sardinia - Italy, to our lab! She is joining us for a 3-month Erasmus+ Master’s internship in medicinal chemistry, working on the development of Leishmania casein kinase 1 inhibitors with potential antiparasitic applications. Many thanks to Prof. Elias Maccioni and the Paul Ehrlich MedChem Euro-PhD Network for making this collaboration possible.

Le Prof. Patrice Le Pape a le plaisir d'annoncer l’arrivée de Halana LIMA DE OLIVEIRA pour une période de 9 mois au Laboratoire. Halana est doctorante à l’Université Fédérale de Pernambuco (UFPE)  – Recife, Brésil dans le service de Mycologie Médicale du Prof. Reginaldo Goncalves de Lima.

Halana va participer au projet ANR Aspergillus One Health sur le volet fitness. Elle profitera de cette formation pour inclure dans ses expérimentations Sporothrix sp. son pathogène d’élection. 

Nous avons le plaisir d’accueillir au Laboratoire Aura Lucia Chacon Parra (Universidad Nacional de Colombia – UNAL), actuellement doctorante au sein de l’équipe du Pr Deborah Castelo-Branco (Universidade Federal do Ceará, Fortaleza, Brésil) avec laquelle nous entretenons une collaboration sur l'impact des composés agrochimiques sur la résistance des levures.

Son séjour, du 11 septembre 2025 au 31 mars 2026 est rendu possible grâce à l’obtention par Lucia d’une bourse fédérale d’étude du CNPq.

Back at IICiMed Lab after an inspiring symposium dedicated to the CK1 kinase family! https://ck1.sci.muni.cz/ MILESTONE International Conference.
A big thank you to Vítězslav Bryja and Marie Doležalová from CEITEC - Central European Institute of Technology Masaryk University, Brno – Czech Republic, for the outstanding organization and warm hospitality.
Prof. Pascal Marchand is proud to have presented our latest research on CTN1122 hit compound and its derivatives as CK1 inhibitors, contributing to the fight against leishmaniasis.

The IICiMed Lab is at RICT2025 in Orléans-France, July 2-4, 2025. This is a fantastic opportunity to share the latest results of the TEXLEISH ANR project, which focuses on CK1 inhibitors as antileishmanial agents.

https://www.rict2025.org/

We are honoured to welcome Assoc. Prof. Florence McCarthy from University College Cork Ireland to the IICiMed Lab for one month, and to announce that he has been awarded the 2025 France Excellence Research Residency grant.

Brazilian collaborators from Universidade Federal de Pernambuco, Recife - Prof. Teresinha Silva, and from Universidade Federal de Alagoas, Maceio - Prof. Thiago Aquino, are also visiting us as part of the CAPES-COFECUB programme.
This is an excellent opportunity to meet their compatriots, Prof. Daniel Assis Santos and Prof. Rafael Bastos, from the Universidade Federal de Minas Gerais and the Universidade Federal do Rio Grande do Norte respectively, who are here as part of another CAPES-COFECUB collaboration managed by Prof. Florent Morio.
Many thanks to Assoc. Prof. Isabelle Ourliac-Garnier for organising such an inspiring meeting with the three networks (PIs, PhD students, postdoctoral researchers, biologists and chemists). Bringing different networks together adds value to scientific exchanges, builds new collaborations and allows us to move forward.
COLLABORATION IS KEY!

Delighted to welcome Prof. Daniel Assis Santos (Universidade Federal de Minas Gerais) and Prof. Rafael Bastos (Universidade Federal do Rio Grande do Norte) for two inspiring weeks as part of our CAPES-COFECUB collaboration.

Le congrès qui s'est déroulé début juin à la Faculté de Pharmacie a été un réel succès avec près de 170 participants :

https://gp2a.org/index.php/gp2a-2025-paul-ehrlich-medchem-2025-nantes-france-june-11th-to-13th-2025/

En plus des 8 conférences principales, nous avons reçu 102 résumés d'abstracts pour établir le programme suivant :
- 17 communications orales (15 minutes)
- 8 Prix Paul Ehrlich (15 minutes)
- 77 posters : 52 présentations de posters (3 sessions) et 25 communications flash (3 minutes).
17 pays étaient représentés à la conférence, avec 51 participants à l'atelier pré-conférence (Artificial Intelligence in Drug Discovery : A New Era of Molecular Design) par le Dr. Dylan SERILLON (PharmD, PhD) WhiteLab Genomics, un de nos anciens étudiants.

It was a great pleasure to welcome Assoc. Prof. Vânia Moreira as an invited researcher at the Faculté de Pharmacie de Nantes Université.
Amazing talk dealing with "Anti-infective activities of Abietane-type diterpenoids. A tale of antimicrobial compounds and surfaces" 👏 👏

Thrilled to welcome Dr. Kássia Jéssica Galdino da Silva this week to Nantes Université !

She joins us as a postdoctoral researcher for 10 months from the Universidade Federal do Rio Grande do Norte (team of Prof. Rafael Bastos), and is the very first visiting researcher from our four-year CAPES-COFECUB program — a collaboration with Prof. Daniel Assis Santos (Universidade Federal de Minas Gerais, Brazil 🇧🇷).

Project Capes-Cofecub Me1080/25 "France-Brazil collaboration in a « One Health » approach to fight antifungal resistance"

A warm welcome to Kássia as we continue strengthening scientific ties between France and Brazil!

Looking forward to the exciting work ahead.

Florent Morio

Rafael Bastos 

Kássia Jéssica Galdino da Silva

Daniel Assis Santos

Isabelle Ourliac-Garnier

Rose-Anne Lavergne

Communication invitée Workshop Candida "Insights into virulence factors, immune regulationand antifungal drug resistance"

Last week, IICiMed Lab had the great pleasure of attending the CaPF (Consortium against Parasites and Fungi) conference in Lille.
Many thanks to Faustine Dubar and the local organisers for arranging such a successful event, which brought together biologists, chemists and hospital researchers to discuss human and veterinary health.
We were delighted to present some of the lab's results: 'Candida auris: an emerging multidrug-resistant fungal pathogen' (Prof. Patrice Le Pape) and 'Targeting casein kinase 1 as a novel strategy for the design of anti-infective agents' (Prof. Pascal Marchand).
We look forward to meeting our scientific community again in Strasbourg next year. Prof. Elisabeth Davioud-Charvet-Charvet will be welcoming us.

It was a pleasure to reconnect with Dr. Manu De Rycker at the Drug Discovery Unit, University of Dundee, School of Life Sciences - What incredible facilities! I also had the opportunity to discuss the exciting future directions of the Leishmania casein kinase 1 project, ANR (Agence nationale de la recherche) TEXLEISH, with Prof. Gopal Sapkota from MRC PPU.
A special thank you to Dr. Najma Rachidi from the Institut Pasteur for this valuable collaboration and the opportunity to come and to exchange ideas on our joint projects dedicated to combating neglected tropical diseases.

Nous avons le plaisir d’accueillir le Dr Hossein Zarrinfar, du département de Mycologie Médicale de l’Université de Mashhad (Iran), pour une visite de trois mois à partir du 6 février 2025. Cette mission est rendue possible grâce à une bourse obtenue par le Dr Zarrinfar auprès de la Faculté de Médecine de Mashhad.

Conférence invitée. Morio F. III Nouvelles technologies pour l'étude des champignons : CRISPr